UPDATE 1-UK rejects adult Novartis CAR-T therapy, after 'yes' in kids


Health authorities in England have rejected a pricey CAR-T cell therapy from Novartis for adults with blood cancer, two weeks after endorsing its use in children and young people. The National Institute for Health and Care Excellence said Kymriah was not cost-effective for adult lymphoma.



from Biotech News